Stockscreener 앱 받기
52.69
0.04%
-0.02
시장 영업 전:
52.70
0.01
+0.02%
Terns Pharmaceuticals Inc 주식(TERN)의 최신 뉴스
This Terns Pharmaceuticals analyst is no longer bullish; here are top 4 downgrades for Monday - MSN
TERN SEC FilingsTerns Pharmaceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Are TERN, SLNO, WSR Obtaining Fair Deals for their Shareholders? - Sahm
Merck to acquire Terns Pharmaceuticals for $53 per share in cash - MSN
Merck to buy Terns for $6.7 billion to grow in blood cancers - MSN
TERN Maintained by JP Morgan -- Price Target Raised to $44.50 - GuruFocus
Merck's $6.7 billion Terns Pharmaceuticals acquisition may face rival interest: Analyst - MSN
Wall Street Recap: Is Terns Pharmaceuticals Inc a top pick in the sector2026 Trading Volume Trends & Weekly Stock Performance Updates - baoquankhu1.vn
TERN Stock Chart | TERNS PHARMACEUTICALS INC (NASDAQ:TERN) - ChartMill
Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B - MSN
TERN PE Ratio & Valuation, Is TERN Overvalued - Intellectia AI
Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti Investigates Proposed Sale - National Today
User - The Chronicle-Journal
Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? - Finviz
Merck nears $6 billion deal to buy Terns Pharma: Report - MSN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Terns Therapeutics, Inc. (Nasdaq – TERN), Whitestone REIT (NYSE – WSR), Rallybio Corporation (Nasdaq – RLYB), Day One Biopharmaceuticals, Inc. (Nasda - ChartMill
Merck & Co. Deepens Hematology Pipeline with $6.7 Billion Terns Acquisition - CHEManager.
Merck begins tender offer to buy Terns Pharmaceuticals - MSN
TERN Stock Price, Quote & Chart | TERNS PHARMACEUTICALS INC (NASDAQ:TERN) - ChartMill
Merck & Co Inc Stock (MRK) Moved Up by 3.18% on Apr 8: Facts Behind the Movement - TradingKey
$680 Million in Daily Turnover Crowns Terns as Most Active Stock Ahead of Merck Deal - Bitget
How Merck slashed its bid for Terns Pharmaceuticals by $1B after reviewing cancer drug trial data - The Business Journals
Why Terns Pharmaceuticals Stock Rocked the Market in March - The Globe and Mail
Mizuho reiterates Terns Pharmaceuticals stock rating at Neutral By Investing.com - Investing.com Canada
Terns’ drug may not be as competitive as many initially thought - statnews.com
Mizuho reiterates Terns Pharmaceuticals stock rating at Neutral - Investing.com
Leerink Partners Downgrades Terns Pharmaceuticals(TERN.US) to Hold Rating - Moomoo
Merck moves to seal $53-a-share takeover of Terns Pharmaceuticals - Indian Pharma Post
Merck Lowered Terns Pharmaceuticals Offer Price After Trial Data Review - Sahm
Merck’s US$6.7b Terns Deal And What It Means For Valuation - Sahm
Merck’s (NYSE:MRK) Terns Deal And S&P 500 Valuation Impact Explained - Kalkine Media
William Blair Downgrades Terns Pharmaceuticals(TERN.US) to Hold Rating, Announces Target Price $53 - Moomoo
William Blair downgrades Terns Pharmaceuticals stock rating on Merck deal By Investing.com - Investing.com Canada
Merck To Acquire Terns Pharmaceuticals - citybiz
What's Going On With Merck Stock Tuesday? - Benzinga
Terns rebuffed a higher bid before selling to Merck - BioPharma Dive
Merck (MRK) Initiates Tender Offer for Terns Pharmaceuticals - GuruFocus
Merck begins tender offer to buy Terns Pharmaceuticals (MRK:NYSE) - Seeking Alpha
Merck begins tender offer to acquire Terns Pharmaceuticals, Inc. - marketscreener.com
Merck launches tender offer to acquire Terns Pharmaceuticals for $53 per share - StreetInsider
Merck Begins Tender Offer To Acquire Terns Pharmaceuticals, Inc. - TradingView — Track All Markets
Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc. - Bluefield Daily Telegraph
[SC 14D9] Terns Pharmaceuticals, Inc. Tender Offer Recommendation - Stock Titan
Merck (NYSE: TERN) to acquire Terns for $53.00 per share cash - Stock Titan
Shareholder Alert: Ademi LLP investigates whether Terns Pharmaceuticals Inc. is obtaining a ... - Bluefield Daily Telegraph
Shareholder Alert: Ademi LLP investigates whether Terns - GlobeNewswire
Merck nears deal to buy Terns Pharmaceuticals - MSN
0.45%
0.77%
자본화:
|
볼륨(24시간):